NNRTI


Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for NNRTI

References in periodicals archive ?
The presence of high rates of NNRTI resistance mutations conferring resistance to ETR in nearly 50% of subjects is likely to reflect virological failure on first- or second-line NNRTI-based ART regimens.
Other new INSTIs, NNRTIs and PIs are currently being evaluated in phase I/II studies, as are improved formulations for delivery, such as injectable ARVs, including cabotegravir and rilpivirine.
Brazilian treatment guidelines recommend NNRTI based regimens as first line ART since 2000, earlier than the ART scale up in other low/middle-income countries, (19,20) and this may have negatively impacted the emergence of NNRTI TDR in our setting.
This limitation can be justified by standard criteria currently using the protocol for treatment of adult HIV positive patients, which recommends that the initiation of ART is performed with 2 NRTI + NNRTI, particularly EFZ600 + ATC.
If the severe rash was due to EFV, neither NNRTI should be given again and a protease-inhibitor based regimen used instead.
NNRTI drug resistant mutations in the RT gene at baseline and follow up NNRTI mutations ART regimen K103 N Y181 C Y188C Baseline (N = 8) Nil Nil Nil Post Sd-NVP (N = 12) 3 1 1 * * 1 woman had more than one mutation at follow up
In NNRTI-naive patients with no NNRTI and at least 2 fully active NRTIs on genotyping, a simple switch to 2 NRTIs + NNRTI may be appropriate.
Efficacy and tolerability of TMC125 in HIV patients with NNRTI and PI resistance at 24 weeks: TMC125-C223.
DPC 083 - has excellent activity against resistant strains of virus, including virus resistant to other NNRTIs.
Four of the patients taking NNRTI regimens switched to PI therapy later in pregnancy, said Dr.
I found this particularly interesting because the current protease inhibitors and some NNRTI drugs are known to cause abnormal redistribution of body fat and potentially fatal liver toxicities.
Capravirine is an NNRTI in phase III clinical trials by Agouron Pharmaceuticals.
Working with the manufacturer, researchers from the California Collaborative Treatment Group tested 164 patients and detected NNRTI hypersusceptibility in 24%.
This marks the first time the panel has suggested a combination regimen containing an NNRTI as a preferred first-line treatment option.